Live from the NIH registry
Studies recruiting near Tulsa right now
Top 25 of 172 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Genentech, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma (5.3 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Crystalys Therapeutics
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2, Phase 3
Interventional 740 participants sought
Corxel Investigational Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Corxel Pharmaceuticals
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 25 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Natalie Warren Bryant Cancer Center at Saint Francis — Tulsa, Oklahoma (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
Alcohol Drinking, Heavy Drinking
N/A
Interventional 150 participants sought
University of Oklahoma Schusterman Center - Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12155 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6047) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Phase 2
Interventional 128 participants sought
Saint Francis Children's Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: St. Jude Children's Research Hospital
Oklahoma Study of Native American Pain Risk III: Stress and Resilience
Discrimination, Racial, Stress Physiology
N/A
Observational 220 participants sought
University of Oklahoma - Schusterman Center — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Coronary Artery Disease, High Risk Percutaneous Coronary Intervention
N/A
Interventional 358 participants sought
Oklahoma Heart Hillcrest Medical — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Supira Medical
Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
Bipolar Depression
Phase 1, Phase 2
Interventional 20 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Pancreas Cancer
N/A
Observational 50 participants sought
Stephenson Cancer Center- Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension
N/A
Observational 900 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: United Therapeutics
Dose-Dependent Effects of Low-Intensity Focused Ultrasound
Healthy Controls
N/A
Interventional 66 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Annovis Bio Inc.
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: DalCor Pharmaceuticals
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 28 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: TR Therapeutics
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Prurigo Nodularis
Phase 3
Interventional 18 participants sought
Vital Prospects Clinical Research Institute - Tulsa- Site Number : 8400002 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Sanofi
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
Depression
Phase 2
Interventional 75 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 195 participants sought
Leo Pharma Investigational site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: LEO Pharma
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Acute Treatment of Migraine
Phase 1
Interventional 16 participants sought
Central States Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Pfizer